Conclusions: Patients with primary Kaposi sarcoma experience a 7.4% increased risk of SPNs compared to the RP. Patients 25-29 years old at time of diagnosis display the highest risk of SPNs. Around 2 to 11 months after Kaposi sarcoma diagnosis mark an increased risk of Non-Hodgkin lymphoma development. Male Kaposi sarcoma patients tend to be more at risk to develop malignancies than the RP. Patients who are diagnosed with primary Kaposi sarcoma should be followed with these risks in mind.Legal entity responsible for the study: The authors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.